跳至主要内容
临床试验/NCT00499304
NCT00499304已完成不适用

Diagnosing Expiratory Flow Limitation in COPD Patients With the Forced Oscillation Technique Using Linear Regression in the Time Frequency Domain

Medical Center Alkmaar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2006年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1

研究概览

简要总结

The aim of this study is to distinguish COPD patients with expiratory flow limitation in body plethysmography (open loop) from the patients without expiratory flow limitation in body plethysmography (closed loop) with the obtained FOT parameters.

详细描述

In daily practice the expiratory flow limitation is measured by body plethysmography. An open loop in body plethysmography shows expiratory flow limitation in COPD patients. But body plethysmography requires that the patient quietly sits in a closed box and is not able to follow changes breath by breath. The goal of this study is to validate the Forced oscillation technique (FOT) for measuring expiratory flow limitation in COPD patients.30 COPD patients with an open loop in body plethysmography are compared to 30 COPD patients with a closed loop. The methods used in this study are the maximal overlap discrete short time Fourier transform (MODFT) combined with a total least squares analysis. It is hypothesized that the obtained FOT parameters are able to distinguish the patients with expiratory flow limitation in body plethysmography from the patients without expiratory flow limitation in body plethysmography.Secondary study questions are: 1) to what extend are the FOT parameters distorted by breathing artifacts and measurement noise. 2)What changes can be detected by FOT in expiratory flow limitation after administration of salbutamol.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presenting to the outpatient clinic
  • Age 50-80 years
  • Diagnosed with COPD according to the standard criteria
  • Gold Stage II to IV COPD
  • Current or ex-smokers (at least 10 PY)
  • Stable disease (No current exacerbation or exacerbation during the 4 weeks previous to the inclusion)

排除标准

  • History of exacerbation of COPD in the preceding month
  • Upper airway obstruction
  • Allergic Asthma
  • OSAS (obstructive sleep apnea syndrome)
  • Extreme obesity (BMI>35)
  • Clinically manifest cardiac disease (for example clinically relevant congestive heart failure, unstable angina pectoris)

研究者

发起方
Medical Center Alkmaar
申办方类型
Other

研究点 (1)

Loading locations...

相似试验